# ZYNRELEF

NDC: 47426-503
Generic name: BUPIVACAINE and MELOXICAM
Labeler / Manufacturer: Heron Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: INFILTRATION
Marketing started: 20241201

FDA application: NDA211988

## Active ingredients

- BUPIVACAINE: 200 mg/7mL
- MELOXICAM: 6 mg/7mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"47426-503"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=47426-503
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dab484a7-9353-43ba-9e74-7fab910c712b